米非司酮联合米索前列醇应用于剖宫产术后1年内中期妊娠中孕期引产安全性分析

郜丽敏; 张晓平; 刘永莹

doi:10.13898/j.cnki.issn.1000-2200.2015.09.014

米非司酮联合米索前列醇应用于剖宫产术后1年内中期妊娠中孕期引产安全性分析

Safety analysis of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within1-year after cesarean section

摘要

摘要: 目的:探讨剖宫产术后1年内中期妊娠应用米非司酮联合米索前列醇药物引产的效果。方法:观察组为剖宫产术后1年内中期妊娠引产24例,对照组为剖宫产术后2年以上中期妊娠引产30例,均给予米非司酮联合米索前列醇引产。结果:2组在引产成功率、应用米索前列醇总量、应用米索前列醇至胎儿娩出时间、阴道流血量、胎盘残留、住院时间、宫颈裂伤发生率差异均无统计学意义(P>0.05)。结论:米非司酮联合米索前列醇应用于剖宫产术后1年内中期妊娠引产临床效果安全可靠。

Abstract: Objective:To explore the effects of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within 1-year after cesarean section.Methods:The second trimester odinopoeia women within 1-year after cesarean section in 24 cases and more than 2 years after cesarean section in 30 cases were divided into the experimental group and control group,respectively.Two groups were induced labor with mifepristone combined with misoprostol.Results:The differences of the success rate,dosage of misoprostol,time from the use of misoprostol to labor,amount of vaginal bleeding,placental residue,length of stay and incidence of cervical laceration were not statistical significance(P>0.05).Conclusions:The effects of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within 1-year after cesarean section are safe and reliable.

HTML全文

参考文献(12)

施引文献

资源附件(0)